Drug-influenced gingival enlargement (DIGE) is a reaction to specific medications, namely phenytoin, ciclosporin and calcium channel blockers. DIGE is encountered increasingly in clinical practice due to the widespread use of calcium channel blocker drugs particularly. Approaches to its management are discussed in this review.
Methods: Narrative review of the literature and discussion of clinical implications.
Findings: Management of DIGE involves nonsurgical treatment and may require surgical reduction of the overgrown gingival tissues. Management is complicated by the difficulties in achieving adequate plaque control, given the unfavourable contour of the enlarged gingival tissues, and the high frequency of recurrence of DIGE after surgical management. Replacing the drug involved can be very beneficial in selected cases, but the management of the underlying medical condition limits its application. The decision to replace a drug is not the responsibility of the dental practitioner, but the patient's physician may make it after consultation.
Conclusions: Management of DIGE can be challenging and may require close co-operation between the dental practitioner and a hygienist, a periodontist and the patient's physician. Long term supportive maintenance programmes need to be in place for optimal outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1308/205016820828463816DOI Listing

Publication Analysis

Top Keywords

drug-influenced gingival
8
gingival enlargement
8
calcium channel
8
management dige
8
gingival tissues
8
dental practitioner
8
patient's physician
8
management
7
dige
5
management drug-influenced
4

Similar Publications

Gingival enlargement (GE) is characterized by the overgrowth of gingival tissues, often exacerbated by dental biofilm and certain medications or substances. This report presents a case of severe GE in a 61-year-old male with generalized stage 4, grade C periodontitis linked to methamphetamine use, which the patient disclosed occurred during a period of homelessness. The treatment involved antibiotic therapy, extractions, gingivectomy, gingivoplasty, and osteoplasty to facilitate future oral rehabilitation.

View Article and Find Full Text PDF

Drug-influenced gingival enlargement (DIGE) is a well-known adverse drug reaction associated with multiple medications. Although a benign condition, DIGE can have a significant impact on patients' aesthetic comfort and function. A surgical resection approach is usually proposed to treat severe and generalized DIGE.

View Article and Find Full Text PDF

Drug-influenced gingival enlargement is a common side effect associated with certain medications, particularly calcium channel blockers like nifedipine, which has been extensively documented. However, the occurrence of nifedipine-influenced masticatory mucosa overgrowth in edentulous patients is rare. Here, we present a case of nifedipine-influenced mucosal enlargement persisting in a 67-year-old edentulous patient 3 months after the extraction of all his teeth.

View Article and Find Full Text PDF

Antihypertensives such as amlodipine, which is a family of calcium channel blockers (CCBs), possess a limitation by causing gingival enlargement on long-term use. Gingival enlargement hinders the patient's oral hygiene maintenance and causes more plaque accumulation and inflammation. The severity of the condition is dependent on dose and duration.

View Article and Find Full Text PDF

Gingival overgrowth approached using recent mechanical and laser technologies: A case report.

Exp Ther Med

February 2024

Department of Medical and Surgical Emergencies in Dental Medicine, Anesthesia and Sedation, Faculty of Dental Medicine, Titu Maiorescu University of Bucharest, Bucharest 031593, Romania.

Gingival enlargement is a side effect of different drug classes, with calcium channel blockers being among the most often cited examples. Most often accompanied by a disruption in the oral biofilm, this form of gingival overgrowth, with histological signs of hyperplasia and hypertrophy, becomes a chronic inflammatory condition with the oral biofilm a primary cause. This periodontal disease is now classified as 'dental biofilm-induced gingivitis', and its preferred name is drug-influenced gingival expansion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!